Ne Rx Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NE RX PHARMA, and what generic and branded alternatives to NE RX PHARMA drugs are available?
NE RX PHARMA has four approved drugs.
Drugs and US Patents for Ne Rx Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ne Rx Pharma | METHSCOPOLAMINE BROMIDE | methscopolamine bromide | TABLET;ORAL | 216786-001 | Feb 1, 2024 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Ne Rx Pharma | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 217197-001 | May 9, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Ne Rx Pharma | METOLAZONE | metolazone | TABLET;ORAL | 216216-002 | Oct 25, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Ne Rx Pharma | BUTALBITAL AND ACETAMINOPHEN | acetaminophen; butalbital | TABLET;ORAL | 214955-001 | Aug 16, 2022 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Ne Rx Pharma | METOLAZONE | metolazone | TABLET;ORAL | 216216-003 | Oct 25, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.